Is this a turning point for the Diageo share price?

The Diageo share price is at an eight-year low. Is this FTSE 100 favourite simply too cheap to ignore? Roland Head takes a closer look.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Business manager working at a pub doing the accountancy and some paperwork using a laptop computer

Image source: Getty Images

Down 40% in three years, I have to admit the Diageo (LSE: DGE) share price is starting to look tempting to me.

Brands such as Johnnie Walker, Guinness and Gordon’s have been around for over 200 years. They seem like safe long-term performers to me. After all, unlike tobacco, alcohol consumption has been the norm in much of the world for 1,000 years, or more.

However, the fact that Diageo shares are trading at levels first seen eight years ago is a painful reminder that this situation isn’t quite so simple.

One too many (problems)?

Recent headlines have focused on the possible impact of US tariffs on Diageo’s sales. The company imports much of its US product from Mexico and Canada. Hard-pressed American consumers might not welcome price rises.

Market conditions are already a little slow. Sales fell 0.6% during the six months to 31 December, while volumes were 0.2% lower. In the US market, which generates about 40% of sales, volumes fell 3% during the half year.

The company has now abandoned its previous guidance for medium-term sales growth of 5-7% a year. This target no longer had any serious credibility with the market, so it’s a sensible decision, in my view. But it’s also a reminder of an uncertain outlook.

Will we stop drinking?

There are fears among some investors that Diageo’s post-pandemic slowdown’s only the start of a broader reduction in alcohol consumption. Younger generations are said to be drinking less than older cohorts.

For existing drinkers, new weight-loss drugs are said to be proving helpful as a way of reducing problem drinking. Veteran fund manager Terry Smith cited this factor as one reason for his decision to sell his fund’s Diageo shares last year, having held them since 2010.

It’s perhaps a sobering statistic to realise that in the US, research suggests that half the alcohol sold each year is consumed by just 10% of drinkers. If they cut back, it could have a noticeable impact on demand.

Diageo: a contrarian opportunity?

Fundamentally, I reckon Diageo remains a high-quality business. Although debt levels are higher than I’d like to see, I still think the shares are starting to look interesting at current levels.

One valuation measure I use is to compare a company’s earnings before interest and tax with its enterprise value (market-cap plus net debt).

On this measure, Diageo shares trade on a profit multiple of 14. That’s a level I consider to be reasonable value for a growing business. And that’s the big question.

Ultimately, I think Diageo’s attraction as an investment today depends on whether alcoholic drinks are going to become a legacy business that’s in decline, like cigarettes.

If alcohol follows tobacco then I would say Diageo share are still too expensive. But if the drinks market returns to growth in line with pre-pandemic norms, I think the shares could offer value at current levels.

Are Diageo shares at a turning point today? I think we’re close, but I’m not quite convinced. This business will stay on my watchlist for now.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »